{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T08:51:19Z","timestamp":1782982279156,"version":"3.54.5"},"reference-count":71,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019711","name":"London Health Sciences Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012118","name":"Ontario Institute for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012118","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010564","name":"Academic Medical Organization of Southwestern Ontario","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008481","name":"Association of Canadian Universities for Research in Astronomy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008481","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ijrobp.2025.12.050","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T16:07:57Z","timestamp":1767974877000},"page":"306-319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Practical Aspects of Delivering Radiation for Polymetastatic Disease"],"prefix":"10.1016","volume":"125","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1058-4364","authenticated-orcid":false,"given":"Hatim","family":"Fakir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gage","family":"Redler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn S.","family":"Bauman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy J.","family":"Caudell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"O\u2019Neil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Lessard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Millman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Celinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohann J.M.","family":"Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy K.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2025.12.050_bib0001","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/138161210789941847","article-title":"Recent advances in cancer therapy: An overview","volume":"16","author":"Urruticoechea","year":"2009","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0002","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.prro.2024.04.018","article-title":"External beam radiation therapy for palliation of symptomatic bone metastases: An ASTRO clinical practice guideline","volume":"14","author":"Alcorn","year":"2024","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0003","article-title":"A comprehensive perspective on educational and economic barriers for utilization of palliative radiation therapy in hospice: A narrative review","volume":"9","author":"Hendee","year":"2024","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0004","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jbo.2014.11.001","article-title":"Quality of life after palliative radiotherapy in bone metastases: A literature review","volume":"4","author":"McDonald","year":"2015","journal-title":"J Bone Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0005","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ijrobp.2019.07.009","article-title":"Net pain relief after palliative radiation therapy for painful bone metastases: A useful measure to reflect response duration? A further analysis of the Dutch bone metastasis study","volume":"105","author":"Spencer","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0006","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.prro.2011.12.004","article-title":"Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline","volume":"2","author":"Tsao","year":"2012","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0007","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3747\/co.v16i3.304","article-title":"The emerging role of IG-IMRT for palliative radiotherapy: A single-institution experience","volume":"16","author":"Samant","year":"2009","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0008","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/SPC.0000000000000639","article-title":"A shift from simple to sophisticated: Using intensity-modulated radiation therapy in conventional nonstereotactic palliative radiotherapy","volume":"17","author":"Dennis","year":"2023","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0009","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3389\/fonc.2019.00337","article-title":"Stereotactic body radiotherapy (SBRT) for oligometastatic spine metastases: An overview","volume":"9","author":"Zeng","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0010","first-page":"183","article-title":"The evolving role of radiation therapy as treatment for liver metastases","volume":"2","author":"Alrabiah","year":"2022","journal-title":"J Natl Cancer Cent"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0011","doi-asserted-by":"crossref","DOI":"10.1177\/1533033818816080","article-title":"Conformal radiation therapy or stereotactic body radiation therapy: Institutional experience in the management of colorectal liver metastases by radiation therapy","volume":"17","author":"He","year":"2018","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0012","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12904-024-01548-7","article-title":"A randomized phase III trial of stereotactic ablative radiotherapy for patients with up to 10 oligometastases and a synchronous primary tumor (SABR-SYNC): Study protocol","volume":"23","author":"Palma","year":"2024","journal-title":"BMC Palliat Care"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0013","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/s12885-021-08020-2","article-title":"Ablative radiation therapy to restrain everything safely treatable (ARREST): Study protocol for a phase I trial treating polymetastatic cancer with stereotactic radiotherapy","volume":"21","author":"Bauman","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0014","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.ijrobp.2024.06.033","article-title":"Ablative radiation therapy to restrain everything safely treatable (ARREST): A phase 1 study of stereotactic ablative radiation therapy for polymetastatic disease","volume":"120","author":"Nguyen","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217897","article-title":"Strategic radiotherapy: A new proof of concept","volume":"630","author":"De Felice","year":"2025","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0016","article-title":"Stereotactic ablative radiotherapy for primary renal cell carcinoma","volume":"44","author":"Yang","year":"2024","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0017","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5306\/wjco.v10.i1.14","article-title":"Stereotactic body radiation therapy for non-small cell lung cancer: A review","volume":"10","author":"Prezzano","year":"2019","journal-title":"World J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0018","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jama.2010.261","article-title":"Stereotactic body radiation therapy for inoperable early stage lung cancer","volume":"303","author":"Timmerman","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0019","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/S1470-2045(22)00656-8","article-title":"5-Year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: An individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney)","volume":"23","author":"Siva","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0020","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3171\/2017.1.SPINE16684","article-title":"Stereotactic body radiotherapy for de novo spinal metastases: Systematic review","volume":"27","author":"Husain","year":"2017","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0021","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.prro.2016.08.001","article-title":"Palliative radiation therapy for bone metastases: Update of an ASTRO evidence-based guideline","volume":"7","author":"Lutz","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0022","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.radonc.2017.06.002","article-title":"A review of patterns of practice and clinical guidelines in the palliative radiation treatment of uncomplicated bone metastases","volume":"124","author":"Ganesh","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.110717","article-title":"Stereotactic body radiotherapy for non-spine bone metastases: A meta-analysis and International Stereotactic Radiosurgery Society (ISRS) clinical practice guidelines","volume":"205","author":"Nguyen","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0024","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.prro.2011.01.005","article-title":"Palliative thoracic radiotherapy in lung cancer: An American Society for Radiation Oncology evidence-based clinical practice guideline","volume":"1","author":"Rodrigues","year":"2011","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.111107","article-title":"Definition and requirements for stereotactic radiotherapy: A systematic review","volume":"211","author":"Kuncman","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0026","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4143\/crt.2022.1460","article-title":"Top ten lessons learned from trials in oligometastatic cancers","volume":"55","author":"Tan","year":"2023","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0027","doi-asserted-by":"crossref","first-page":"6045","DOI":"10.21037\/apm-20-847","article-title":"A review of ongoing trials of stereotactic ablative radiotherapy for oligometastatic disease in the context of new consensus definitions","volume":"10","author":"Li","year":"2021","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110505","article-title":"Stereotactic ablative radiotherapy for oligoprogressive solid tumours: A systematic review and meta-analysis","volume":"200","author":"Tan","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0029","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: Long-term results of the SABR-COMET phase II randomized trial","volume":"38","author":"Palma","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0030","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1200\/JCO.2020.38.6_suppl.10","article-title":"Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence (STOMP): Five-year results of a randomized phase II trial","volume":"38","author":"Ost","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0031","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jamaoncol.2020.0147","article-title":"Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: The ORIOLE phase 2 randomized clinical trial","volume":"6","author":"Phillips","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0032","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/jnci\/djac015","article-title":"Randomized trial of first-line tyrosine kinase inhibitor with or without radiotherapy for synchronous oligometastatic EGFR-mutated non-small cell lung cancer","volume":"115","author":"Wang","year":"2023","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0033","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2020.38.15_suppl.e21567","article-title":"Can polymetastatic disease be arrested using SABR? A dosimetric analysis to inform development of a phase I trial","volume":"38","author":"Corkum","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0034","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1158\/2159-8290.CD-21-0003","article-title":"Low-dose radiotherapy reverses tumor immune desertification and resistance to immunotherapy","volume":"12","author":"Herrera","year":"2022","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-025-03281-2","article-title":"Enhancing immunotherapy efficacy with synergistic low-dose radiation in metastatic melanoma: Current insights and prospects","volume":"44","author":"Rafiq","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0036","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ijrobp.2014.01.024","article-title":"Workflow enhancement (WE) improves safety in radiation oncology: Putting the WE and team together","volume":"89","author":"Chao","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0037","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.ijrobp.2025.04.010","article-title":"Advancements in radiation therapy treatment workflows for precision medicine: A review and forward looking","volume":"122","author":"Rong","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0038","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nrclinonc.2012.166","article-title":"Stereotactic body radiotherapy treatment of extracranial metastases","volume":"9","author":"Salama","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0039","doi-asserted-by":"crossref","first-page":"4608","DOI":"10.1038\/s41467-025-59865-1","article-title":"Neoadjuvant with low-dose radiotherapy, tislelizumab, albumin-bound paclitaxel, and cisplatin for resectable locally advanced head and neck squamous cell carcinoma: Phase II single-arm trial","volume":"16","author":"Liu","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0040","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.radonc.2021.06.037","article-title":"High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial","volume":"162","author":"Patel","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0041","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-011487","article-title":"Low-dose radiotherapy enhances the efficacy of PD-L1 blockade and induces the abscopal effect","volume":"13","author":"Laurent","year":"2025","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0042","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1158\/2326-6066.CIR-18-0793","article-title":"Phase II trial of ipilimumab with stereotactic radiation therapy for metastatic disease: Outcomes, toxicities, and low-dose radiation-related abscopal responses","volume":"7","author":"Welsh","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0043","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ccell.2025.02.010","article-title":"Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients","volume":"43","author":"Chen","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0044","doi-asserted-by":"crossref","DOI":"10.1002\/acm2.14303","article-title":"Technical feasibility of novel immunostimulatory low-dose radiation for polymetastatic disease with CBCT-based online adaptive and conventional approaches","volume":"25","author":"Nasser","year":"2024","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0045","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.radonc.2020.04.003","article-title":"Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document","volume":"148","author":"Lievens","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0046","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.ijrobp.2022.10.017","article-title":"Stereotactic body radiation therapy versus conventional radiation therapy in pain relief for bone metastases: A systematic review and meta-analysis","volume":"115","author":"Song","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0047","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1470-2045(21)00196-0","article-title":"Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: An open-label, multicentre, randomised, controlled, phase 2\/3 trial","volume":"22","author":"Sahgal","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0048","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.ijrobp.2011.09.049","article-title":"Maximizing tumor immunity with fractionated radiation","volume":"83","author":"Schaue","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0049","doi-asserted-by":"crossref","unstructured":"Van Dyk J, Galvin JM, Glasgow GP, Podgorsak EB. The Physical Aspects of Total and Half Body Photon Irradiation : A Report of Task Group 29, Radiation Therapy Committee, Association of Physicists in Medicine. AAPM REPORT NO. 17. Published for the American Association of Physicists in Medicine by the American Institute of Physics; 1986. https:\/\/www.aapm.org\/pubs\/reports\/RPT_17.pdf","DOI":"10.37206\/16"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0050","doi-asserted-by":"crossref","DOI":"10.1177\/15330338231180779","article-title":"Feasibility and toxicity of full-body volumetric modulated arc therapy technique for high-dose total body irradiation","volume":"22","author":"Keit","year":"2023","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0051","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.radonc.2022.10.019","article-title":"Lymphocyte sparing normal tissue effects in the clinic (LymphoTEC): A systematic review of dose constraint considerations to mitigate radiation-related lymphopenia in the era of immunotherapy","volume":"177","author":"Venkatesulu","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0052","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ijrobp.2023.08.054","article-title":"Spine stereotactic body radiation therapy without immobilization: Detailed analysis of intrafraction motion using high-frequency kV imaging during irradiation","volume":"118","author":"Remmerts de Vries","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0053","article-title":"Simple immobilization for stereotactic radiotherapy aimed at pelvic metastases","volume":"27","author":"Janssen","year":"2023","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0054","doi-asserted-by":"crossref","DOI":"10.1002\/acm2.13804","article-title":"Comparison of setup accuracy and efficiency between the Klarity system and BodyFIX system for spine stereotactic body radiation therapy","volume":"23","author":"Quan","year":"2022","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0055","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.meddos.2007.01.005","article-title":"Frame-based immobilization and targeting for stereotactic body radiation therapy","volume":"32","author":"Murray","year":"2007","journal-title":"Med Dosim"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0056","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.radonc.2020.05.038","article-title":"Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines","volume":"150","author":"Mir","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0057","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.ijrobp.2010.07.1977","article-title":"Consideration of dose limits for organs at risk of thoracic radiotherapy: Atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus","volume":"81","author":"Kong","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109969","article-title":"Efficacy and safety of SBRT for spine metastases: A systematic review and meta-analysis for preparation of an ESTRO practice guideline","volume":"190","author":"Guninski","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0059","doi-asserted-by":"crossref","first-page":"e597","DOI":"10.1016\/j.ijrobp.2012.03.009","article-title":"International spine radiosurgery consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery","volume":"83","author":"Cox","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0060","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ijrobp.2021.09.004","article-title":"International multi-institutional patterns of contouring practice and clinical target volume recommendations for stereotactic body radiation therapy for non-spine bone metastases","volume":"112","author":"Nguyen","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.clon.2024.103736","article-title":"PTV margins in MR-guided and beam-gated SBRT of liver metastases: GTV dose escalation can reduce the required PTV","volume":"39","author":"Wahlstedt","year":"2025","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0062","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.rpor.2017.07.005","article-title":"Setup uncertainties and PTV margins at different anatomical levels in intensity modulated radiotherapy for nasopharyngeal cancer","volume":"22","author":"Anjanappa","year":"2017","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0063","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s13014-014-0229-z","article-title":"PTV margin definition in hypofractionated IGRT of localized prostate cancer using cone beam CT and orthogonal image pairs with fiducial markers","volume":"9","author":"Oehler","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0064","doi-asserted-by":"crossref","DOI":"10.1177\/15330338211063033","article-title":"Triggered kV imaging during spine SBRT for intrafraction motion management","volume":"20","author":"Koo","year":"2021","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0065","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1426635","article-title":"Early lymphocyte levels and low doses radiation exposure of lung predict lymphopenia in radiotherapy for lung cancer","volume":"15","author":"Kuncman","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0066","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.critrevonc.2018.01.003","article-title":"A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors","volume":"123","author":"Venkatesulu","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0067","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/acm2.13360","article-title":"The use of collimator angle optimization and jaw tracking for VMAT-based single-isocenter multiple-target stereotactic radiosurgery for up to six targets in the Varian Eclipse treatment planning system","volume":"22","author":"Pudsey","year":"2021","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0068","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.31557\/APJCP.2023.24.7.2455","article-title":"Single-isocenter multiple-target SRS planning of five to ten brain metastases using 5 mm multileaf collimator: Relationship between prescription dose, number and volume of targets","volume":"24","author":"Priyadarsini","year":"2023","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0069","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12885-025-13552-y","article-title":"Radiotherapy(R) Integration(I) Strategy for Small(S)-Cell Lung Cancer in Extensive(E) Stage (RISE) with up to 10 metastases- a study protocol of a randomized phase II trial","volume":"25","author":"Kuncman","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0070","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.annonc.2025.09.008","article-title":"ESMO-ESTRO consensus statements on the safety of combining radiotherapy with immune checkpoint inhibitors, VEGF(R) inhibitors, or multitargeted tyrosine kinase inhibitors","volume":"37","author":"van Aken","year":"2026","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.050_bib0071","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626000167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626000167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T08:33:13Z","timestamp":1782030793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301626000167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0360301626000167"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.12.050","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Practical Aspects of Delivering Radiation for Polymetastatic Disease","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.12.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}